litlas
Log inCreate account

Tiziano Barbui

Active 1984–2025

223
Papers
48,563
Citations
123
h-index
217
i10-index

Citations

Citations per year for Tiziano Barbui1948: 2 citations1985: 1 citations1986: 4 citations1987: 8 citations1988: 5 citations1989: 5 citations1990: 18 citations1991: 26 citations1992: 30 citations1993: 32 citations1994: 34 citations1995: 47 citations1996: 80 citations1997: 68 citations1998: 94 citations1999: 107 citations2000: 95 citations2001: 143 citations2002: 111 citations2003: 142 citations2004: 121 citations2005: 196 citations2006: 174 citations2007: 249 citations2008: 337 citations2009: 271 citations2010: 225 citations2011: 251 citations2012: 295 citations2013: 344 citations2014: 305 citations2015: 353 citations2016: 311 citations2017: 251 citations2018: 259 citations2019: 950 citations2020: 1,146 citations2021: 1,021 citations2022: 833 citations2023: 700 citations2024: 1,487 citations2025: 497 citations2026: 2 citations1949–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,587 citing papers, 24.4% of this breakdownItaly: 1,260 citing papers, 11.9% of this breakdownUnited Kingdom: 775 citing papers, 7.3% of this breakdownGermany: 728 citing papers, 6.8% of this breakdownFrance: 637 citing papers, 6% of this breakdownSpain: 469 citing papers, 4.4% of this breakdownCanada: 381 citing papers, 3.6% of this breakdownNetherlands: 367 citing papers, 3.4% of this breakdownChina: 337 citing papers, 3.2% of this breakdownSwitzerland: 252 citing papers, 2.4% of this breakdownAustralia: 228 citing papers, 2.1% of this breakdownJapan: 220 citing papers, 2.1% of this breakdown
0%24.4%Other 22.4%

Institutions

Fields

  • Medicine84.3%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Immunology and Microbiology5.2%
  • Health Professions0.4%
  • Computer Science0.3%
  • Neuroscience0.1%
  • Other0.9%

Topics

  • Myeloproliferative Neoplasms: Diagnosis and Treatment11.1%
  • Acute Myeloid Leukemia Research9.7%
  • Platelet Disorders and Treatments4%
  • Eosinophilic Disorders and Syndromes3.8%
  • Chronic Myeloid Leukemia Treatments3.8%
  • Kruppel-like factors research3.6%
  • Other64%

Coauthors

All papers

Open in search
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Authors: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 cited by 2,693

  2. JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

    Authors: Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali, Heinz Gisslinger, Roger J. Waltzman, Viktoriya Stalbovskaya, Mari McQuitty, Deborah Hunter, Richard Levy, Laurent Knoops, Francisco Cervantes, Alessandro M. Vannucchi, Tiziano Barbui, Giovanni Barosi - New England Journal of Medicine 2012 cited by 1,791

  3. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

    Authors: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Mythri Mudireddy, Carmela Mannarelli, Maura Nicolosi, Annalisa Pacilli, Animesh Pardanani, Elisa Rumi, Vittorio Rosti, Curtis A. Hanson, Francesco Mannelli, Rhett P. Ketterling, Naseema Gangat, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi, Ayalew Tefferi - Journal of Clinical Oncology 2017 cited by 532

  4. Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Authors: Roberto Marchioli, Guido Finazzi, Giorgina Specchia, Rossella Cacciola, Riccardo Cavazzina, Daniela Cilloni, Valerio De Stefano, Elena Maria Elli, Alessandra Iurlo, Roberto Latagliata, Francesca Lunghi, Monia Lunghi, Rosa Maria Marfisi, Pellegrino Musto, Arianna Masciulli, Caterina Musolino, Nicola Cascavilla, Giovanni Quarta, Maria Luigia Randi, Davide Rapezzi, Marco Ruggeri, Elisa Rumi, Anna Rita Scortechini, Simone Santini, Marco Scarano, Sergio Siragusa, Antonio Spadea, Alessia Tieghi, Emanuele Angelucci, Giuseppe Visani, Alessandro Maria Vannucchi, Tiziano Barbui - New England Journal of Medicine 2012 cited by 820

  5. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

    Authors: Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M. Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi - Blood Cancer Journal 2018 cited by 640

  6. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

    Authors: Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy M. Finke, Emnet A Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Jüergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi - Blood 2014 cited by 727

  7. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

    Authors: Tiziano Barbui, Ayalew Tefferi, Alessandro M. Vannucchi, Francesco Passamonti, Richard T. Silver, Ronald Hoffman, Srđan Verstovšek, Ruben A. Mesa, Jean‐Jacques Kiladjian, Rȕdiger Hehlmann, Andreas Reiter, Francisco Cervantes, Claire Harrison, Mary Frances Mc Mullin, Hans Carl Hasselbalch, Steffen Koschmieder, Monia Marchetti, Andrea Bacigalupo, Guido Finazzi, Nicolaus Kröger, Martin Grießhammer, Gunnar Birgegård, Giovanni Barosi - Leukemia 2018 cited by 552

  8. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    Authors: Ayalew Tefferi, Francisco Cervantes, Ruben A. Mesa, Francesco Passamonti, Srđan Verstovšek, Alessandro M. Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison, Ronald Hoffman, Heinz Gisslinger, Nicolaus Kröger, Jüergen Thiele, Tiziano Barbui, Giovanni Barosi - Blood 2013 cited by 379

  9. Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management

    Authors: Ayalew Tefferi, Tiziano Barbui - American Journal of Hematology 2023 cited by 187

  10. A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

    Authors: John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N. Harrison, Mary Frances McMullin, Alessandro M. Vannucchi, Joanne Ewing, Casey L. O'Connell, Jean-Jacques Kiladjian, Adam J. Mead, Elliott F. Winton, David S. Leibowitz, Valerio De Stefano, Murat O. Arcasoy, Craig M. Kessler, Rosalind Catchatourian, Damiano Rondelli, Richard T. Silver, Andrea Bacigalupo, Arnon Nagler, Marina Kremyanskaya, Max F. Levine, Juan E. Arango Ossa, Erin McGovern, Lonette Sandy, Mohamad E. Salama, Vesna Najfeld, Joseph Tripodi, Noushin Farnoud, Alexander V. Penson, Rona Singer Weinberg, Leah Price, Judith D. Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K. Rampal, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman - Blood 2022 cited by 129

  11. Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

    Authors: Tiziano Barbui, Guido Finazzi, Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Heinz Gisslinger, Veronika Buxhofer‐Ausch, Valerio De Stefano, Silvia Betti, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi - Blood 2012 cited by 589

  12. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    Authors: Francesco Passamonti, Toni Giorgino, Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S. Komrokji, Jason Gotlib, Jean‐Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T. Silver, Giulia Benevolo, Francesco Albano, Domenica Caramazza, Michele Merli, Daniela Pietra, Rosario Casalone, Giada Rotunno, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi - Leukemia 2017 cited by 334

  13. Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group

    Authors: Nicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, Markus Ditschkowski, Nico Gagelmann, Martin Grießhammer, Vikas Gupta, Nada Hamad, Claire Harrison, Juan Carlos Hernández‐Boluda, Steffen Koschmieder, Tania Jain, John Mascarenhas, Ruben A. Mesa, Uday Popat, Francesco Passamonti, Nicola Polverelli, Alessandro Rambaldi, Marie Robin, Rachel B. Salit, Thomas Schroeder, Bart L. Scott, Roni Tamari, Ayalew Tefferi, Alessandro M. Vannucchi, Donal P. McLornan, Giovanni Barosi - The Lancet Haematology 2023 cited by 96

  14. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Authors: Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Jean‐Jacques Kiladjian, Stefanie Slot, Sonja Zweegman, Peter A.W. te Boekhorst, Suzan Commandeur, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández‐Maraver, Heike L. Pahl, Martin Grießhammer, Frank Stegelmann, Konstanze Doehner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Françoise Boyer, Gabriel Étienne, Jean‐Christophe Ianotto, Dana Ranta, Lydia Roy, Jean‐Yves Cahn, Claire Harrison, Deepti Radia, Pablo Muxí, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Björn Andréasson, Maria L Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegård, Ayalew Tefferi, Ruben A. Mesa - Journal of Clinical Oncology 2012 cited by 458

  15. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

    Authors: Ayalew Tefferi, Elisa Rumi, Guido Finazzi, Heinz Gisslinger, Alessandro M. Vannucchi, Francesco Rodeghiero, Maria Luigia Randi, Rakhee Vaidya, Mario Cazzola, Alessandro Rambaldi, Bettina Gisslinger, Lisa Pieri, Marco Ruggeri, Irene Bertozzi, Nanna Sulai, Ilaria Carola Casetti, Alessandra Carobbio, Georg Jeryczynski, Dirk R. Larson, Leonhard Müllauer, Animesh Pardanani, J. Thiele, Francesco Passamonti, Tiziano Barbui - Leukemia 2013 cited by 677

  16. Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

    Authors: on behalf of the COMFORT-II Investigators, Claire Harrison, Alessandro M. Vannucchi, J-J Kiladjian, Haifa Kathrin Al‐Ali, Heinz Gisslinger, L. Knoops, Francisco Cervantes, Mark M. Jones, Kang Sun, Mari McQuitty, Viktoriya Stalbovskaya, P. Gopalakrishna, Tiziano Barbui - Leukemia 2016 cited by 509

  17. Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Authors: Roberto Marchioli, Guido Finazzi, Raffaele Landolfi, Jack Kutti, Heinz Gisslinger, Carlo Patrono, Raphael Marilus, A Villegas, Gianni Tognoni, Tiziano Barbui - Journal of Clinical Oncology 2005 cited by 719

  18. Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations

    Authors: Monia Marchetti, Alessandro Maria Vannucchi, Martin Griesshammer, Claire Harrison, Steffen Koschmieder, Heinz Gisslinger, Alberto Álvarez-Larrán, Valerio De Stefano, Paola Guglielmelli, Francesca Palandri, Francesco Passamonti, Giovanni Barosi, Richard T Silver, Rüdiger Hehlmann, Jean-Jacques Kiladjian, Tiziano Barbui - The Lancet Haematology 2022 cited by 113

  19. JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

    Authors: Paola Guglielmelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo, Giacomo Coltro, Silvia Betti, Chiara Maccari, Sara Ceglie, Patrizia Chiusolo, Chiara Paoli, Tiziano Barbui, Ayalew Tefferi, Valerio De Stefano, Alessandro M. Vannucchi - Blood Cancer Journal 2021 cited by 109

  20. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

    Authors: Tiziano Barbui, Alessandro M. Vannucchi, Veronika Buxhofer‐Ausch, Valerio De Stefano, S Betti, Alessandro Rambaldi, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Heinz Gisslinger, Guido Finazzi, Alessandra Carobbio, J. Thiele, Francesco Passamonti, Chiara Falcone, Ayalew Tefferi - Blood Cancer Journal 2015 cited by 268

  21. Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Authors: Raffaele Landolfi, Roberto Marchioli, Jack Kutti, Heinz Gisslinger, Gianni Tognoni, Carlo Patrono, Tiziano Barbui - New England Journal of Medicine 2004 cited by 1,000

  22. Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome

    Authors: Jason Coppell, Paul G. Richardson, Robert J. Soiffer, Paul Martin, Nancy A. Kernan, Allen Chen, Eva C. Guinan, Georgia B. Vogelsang, Amrita Krishnan, Sergio Giralt, Carolyn Revta, Nicole A. Carreau, Massimo Iacobelli, Enric Carreras, Tapani Ruutu, Tiziano Barbui, Joseph H. Antin, Dietger Niederwieser - Biology of Blood and Marrow Transplantation 2009 cited by 596

  23. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

    Authors: Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, Elisabetta Antonioli, Heinz Gisslinger, Veronika Buxhofer‐Ausch, Guido Finazzi, Naseema Gangat, Ayalew Tefferi, Tiziano Barbui - Blood 2011 cited by 447

  24. Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Authors: Sergio Cortelazzo, Guido Finazzi, Marco Ruggeri, Oscar Vestri, Monica Galli, Francesco Rodeghiero, Tiziano Barbui - New England Journal of Medicine 1995 cited by 847